Nanosonics' trophon EPR found effective in hospital study

Nanosonics (ASX:NAN) said its trophon EPR ultrasound probe disinfection device was shown to be more effective than manual methods during a hospital study.

The study found that the manual wipedown method in standard practice across many European hospitals carried a threefold higher risk of cross-contamination compared to use of the trophon EPR system.

Results from the study, conducted by Germany’s University Hospital Münster, were presented at the World Congress of the International Society of Ultrasound in Gynecology and Obstetrics (ISUOG) in Barcelona this week.

The study also highlighted the infection risks posed by not disinfecting ultrasound probe handles, finding that 83% of probe handles showed signs of contamination.

Nanosonics CEO Michael Kavanagh said the study proves that “effective reprocessing of ultrasound probes is essential for proper infection control”.

He said the automated disinfection provided by trophon EPR also has the advantage of affecting the entire probe, including the handle.

Nanosonics entered the German market in March through a partnership with local distributor Miele Professional.

Nanosonics (ASX:NAN) shares were trading 1.83% higher at $1.11 as of around 1.30 pm on Wednesday.